Stavros Anevlavis

1.1k total citations
46 papers, 702 citations indexed

About

Stavros Anevlavis is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Stavros Anevlavis has authored 46 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 7 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Stavros Anevlavis's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Pleural and Pulmonary Diseases (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Stavros Anevlavis is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Pleural and Pulmonary Diseases (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Stavros Anevlavis collaborates with scholars based in Greece, France and United Kingdom. Stavros Anevlavis's co-authors include Demosthenes Bouros, Μarios E. Froudarakis, Αrgyris Τzouvelekis, Ioannis Pneumatikos, Paschalis Steiropoulos, Paschalis Ntolios, Athanasia Pataka, Georgia Karpathiou, Kostas Archontogeorgis and Evangelos Bouros and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Scientific Reports.

In The Last Decade

Stavros Anevlavis

42 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stavros Anevlavis Greece 16 496 134 129 101 74 46 702
Maya Juarez United States 14 431 0.9× 82 0.6× 107 0.8× 62 0.6× 85 1.1× 23 614
Kristine E. Konopka United States 10 409 0.8× 73 0.5× 103 0.8× 39 0.4× 92 1.2× 23 692
Kareem Ahmad United States 11 186 0.4× 77 0.6× 49 0.4× 68 0.7× 33 0.4× 22 371
Atsuko Iwata Japan 13 257 0.5× 103 0.8× 60 0.5× 67 0.7× 61 0.8× 37 509
Sarah L. O’Beirne United States 12 249 0.5× 61 0.5× 65 0.5× 68 0.7× 103 1.4× 28 523
P.A. Corris United Kingdom 15 481 1.0× 102 0.8× 128 1.0× 304 3.0× 68 0.9× 37 861
Guillaume Thouvenin France 16 596 1.2× 67 0.5× 64 0.5× 290 2.9× 175 2.4× 37 903
Jorge Lascano United States 11 190 0.4× 119 0.9× 21 0.2× 100 1.0× 122 1.6× 48 489
Mirna Sučić Croatia 8 136 0.3× 112 0.8× 60 0.5× 45 0.4× 70 0.9× 26 399
Eoin P. Judge Ireland 8 352 0.7× 58 0.4× 110 0.9× 81 0.8× 32 0.4× 18 495

Countries citing papers authored by Stavros Anevlavis

Since Specialization
Citations

This map shows the geographic impact of Stavros Anevlavis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stavros Anevlavis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stavros Anevlavis more than expected).

Fields of papers citing papers by Stavros Anevlavis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stavros Anevlavis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stavros Anevlavis. The network helps show where Stavros Anevlavis may publish in the future.

Co-authorship network of co-authors of Stavros Anevlavis

This figure shows the co-authorship network connecting the top 25 collaborators of Stavros Anevlavis. A scholar is included among the top collaborators of Stavros Anevlavis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stavros Anevlavis. Stavros Anevlavis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Archontogeorgis, Kostas, Evangelia Nena, Pantelis Τ. Nikolaidis, et al.. (2024). Clinical and polysomnographic characteristics of REM-relatedobstructive sleep apnea patients. 37(1). 1–11. 1 indexed citations
4.
Drakopanagiotakis, Fotios, et al.. (2024). Lung Cancer and Interstitial Lung Diseases. Cancers. 16(16). 2837–2837. 6 indexed citations
5.
Voulgaris, Athanasios, Kostas Archontogeorgis, Stavros Anevlavis, et al.. (2023). Effect of compliance to continuous positive airway pressure on exacerbations, lung function and symptoms in patients with chronic obstructive pulmonary disease and obstructive sleep apnea (overlap syndrome). The Clinical Respiratory Journal. 17(3). 165–175. 16 indexed citations
6.
7.
Anevlavis, Stavros, Georgia Karpathiou, Paschalis Ntolios, & Μarios E. Froudarakis. (2022). Two years progression-free survival under vinorelbine metronomic therapy of a patient with metastatic epithelioid hemangioendothelioma. Monaldi Archives for Chest Disease. 92(4).
8.
Froudarakis, Μarios E., Stavros Anevlavis, Charles‐Hugo Marquette, & Philippe Astoul. (2021). Medical Thoracoscopy Implementation after a European Respiratory Society Course Held from 2003 to 2016: A Survey. Respiration. 100(6). 523–529. 2 indexed citations
9.
Anevlavis, Stavros, Periklis Pappas, Paschalis Ntolios, et al.. (2020). Local Anesthesia Thoracoscopy with versus without Midazolam: A Randomized Controlled Trial. Respiration. 99(9). 789–799. 4 indexed citations
10.
Ntolios, Paschalis, Αrgyris Τzouvelekis, Evangelos Bouros, et al.. (2018). Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the adipose‐derived stromal cells‐stromal vascular fraction in idiopathic pulmonary fibrosis. The Clinical Respiratory Journal. 12(6). 2084–2089. 47 indexed citations
11.
Anevlavis, Stavros, Georgia Karpathiou, Argyrios Tzouvelekis, et al.. (2018). Lung function changes after chemoradiation therapy in patients with lung cancer treated by three usual platinum combinations. Journal of Thoracic Disease. 10(9). 5435–5442. 5 indexed citations
12.
Anevlavis, Stavros, et al.. (2018). Is there any role for thoracoscopy in the diagnosis of benign pleural effusions. The Clinical Respiratory Journal. 13(2). 73–81. 6 indexed citations
13.
Tzouvelekis, Argyrios, Paschalis Ntolios, Τheodoros Karampitsakos, et al.. (2017). Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study. Pulmonary Pharmacology & Therapeutics. 46. 48–53. 37 indexed citations
14.
Wallaert, B., Jonas Yserbyt, Stavros Anevlavis, et al.. (2017). Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Multicenter International Study of GELF. Respiration. 93(3). 198–206. 34 indexed citations
15.
Froudarakis, Μarios E., Jérôme Plojoux, Élise Kaspi, et al.. (2017). Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions. The Clinical Respiratory Journal. 12(3). 1011–1016. 17 indexed citations
16.
Nena, Evangelia, et al.. (2015). 016. Prevalence of metabolic syndrome between patients with obstructive sleep apnea. Journal of Thoracic Disease. 7(1).
17.
Ntolios, Paschalis, Τheodoros Karampitsakos, Evangelia Nena, et al.. (2015). Sleep quality among patients with idiopathic pulmonary fibrosis. PA3842–PA3842. 2 indexed citations
18.
Steiropoulos, Paschalis, Evangelia Nena, Μαρία Αντωνιάδου, et al.. (2014). Differences in prevalence of metabolic syndrome (MS) between male and female patients with moderate and severe obstructive sleep apnea. The definition is certainly an important factor. European Respiratory Journal. 44(Suppl 58). P2295–P2295. 1 indexed citations
19.
Anevlavis, Stavros, Ioannis Sotiriou, Michael I. Koukourakis, et al.. (2014). Prognostic Factors in Patients Presenting with Pleural Effusion Revealing Malignancy. Respiration. 87(4). 311–316. 51 indexed citations
20.
Trisolini, Rocco, Stavros Anevlavis, Carmine Tinelli, Paolo Emilio Orlandi, & Marco Patelli. (2013). CT pattern of lymphadenopathy in untreated patients undergoing bronchoscopy for suspected sarcoidosis. Respiratory Medicine. 107(6). 897–903. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maya Juarez Breakdown of academic impact, for papers by Kristine E. Konopka Breakdown of academic impact, for papers by Kareem Ahmad Breakdown of academic impact, for papers by Atsuko Iwata Breakdown of academic impact, for papers by Sarah L. O’Beirne Breakdown of academic impact, for papers by P.A. Corris Breakdown of academic impact, for papers by Guillaume Thouvenin Breakdown of academic impact, for papers by Jorge Lascano Breakdown of academic impact, for papers by Mirna Sučić Breakdown of academic impact, for papers by Eoin P. Judge
Rankless by CCL
2026